ESN-X1

N/A

Report date: 2024/12/03 15:47:27
NMEFirst In Class

Base Information

Drug NameESN-X1
Drug Alias NameESN-X1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitorsTumor necrosis factor superfamily member 15 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3Tumor necrosis factor superfamily member 15
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnveda Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnveda Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A